Legend Biotech Corp ADR (NASDAQ: LEGN) kicked off on Monday, down -7.15% from the previous trading day, before settling in for the closing price of $28.13. Over the past 52 weeks, LEGN has traded in a range of $25.71-$45.30.
During the last 5-year period, the sales growth of Healthcare Sector giant was 0.82%. While this was happening, its average annual earnings per share was recorded -69.75%. With a float of $180.91 million, this company’s outstanding shares have now reached $184.69 million.
Legend Biotech Corp ADR (LEGN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Legend Biotech Corp ADR is 2.05%, while institutional ownership is 44.43%. The most recent insider transaction that took place on Nov 17 ’25, was worth 6,166,620. Before that another transaction happened on Sep 26 ’25, when Company’s Director proposed sale 1,000 for $33.28, making the entire transaction worth $33,285.
Legend Biotech Corp ADR (LEGN) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 0.14 earnings per share (EPS), higher than consensus estimate (set at -0.34) by 0.49. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -69.75% per share during the next fiscal year.
Legend Biotech Corp ADR (NASDAQ: LEGN) Trading Performance Indicators
Take a look at Legend Biotech Corp ADR’s (LEGN) current performance indicators. Last quarter, stock had a quick ratio of 2.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.31, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach 0.50 in one year’s time.
Technical Analysis of Legend Biotech Corp ADR (LEGN)
Looking closely at Legend Biotech Corp ADR (NASDAQ: LEGN), its last 5-days average volume was 3.02 million, which is a jump from its year-to-date volume of 1.49 million. As of the previous 9 days, the stock’s Stochastic %D was 54.73%.
During the past 100 days, Legend Biotech Corp ADR’s (LEGN) raw stochastic average was set at 9.49%, which indicates a significant decrease from 35.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.49 in the past 14 days, which was higher than the 1.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $30.83, while its 200-day Moving Average is $33.93. However, in the short run, Legend Biotech Corp ADR’s stock first resistance to watch stands at $27.96. Second resistance stands at $29.79. The third major resistance level sits at $31.71. If the price goes on to break the first support level at $24.20, it is likely to go to the next support level at $22.27. Now, if the price goes above the second support level, the third support stands at $20.44.
Legend Biotech Corp ADR (NASDAQ: LEGN) Key Stats
The company with the Market Capitalisation of 4.82 billion has total of 184,690K Shares Outstanding. Its annual sales at the moment are 627,240 K in contrast with the sum of -177,030 K annual income. Company’s last quarter sales were recorded 272,330 K and last quarter income was -39,690 K.
